| Abstract:[Objective]?To evaluate the effect of the Huai River Basin Upper Gastrointestinal Cancer Early Diagnosis and Treatment Project in Yandu District, and to assess its impact on the incidence and mortality of malignant tumors in Yandu District.
[Methods]?Using cluster sampling, data were collected from participants of the Huai River Basin Upper Gastrointestinal Cancer Early Diagnosis and Treatment Project in Yandu District from 2013 to 2017, as well as cancer incidence and mortality data from the Yandu District Cancer Registry from 2013 to 2020. The screened population was defined as the screening group, and those who did not participate in the project were defined as the unscreened group. Relative risk was used to evaluate the impact of the screening project on the risk of incidence and mortality in Yandu District. Cost-effectiveness analysis was used to evaluate the economic benefits of the screening project.
[Results]?A total of 47,717 individuals were included in the cohort from 2013 to 2017, including 13,335 in the screening group and 34,382 in the unscreened group. Compared with the unscreened group, the screening group had a 72% higher risk of esophageal cancer (RR=1.72, 95%CI=1.49–1.99, P<0.05), a 73% higher risk of gastric cancer (RR=1.73, 95%CI=1.43–2.08, P<0.05), and a 29% higher risk of all malignancies (RR=1.29, 95%CI=1.19–1.41, P<0.05). The screening group had a 28% higher risk of esophageal cancer mortality (RR=1.28, 95%CI=0.89–1.79, P=0.16), which was not statistically significant, a 48% higher risk of gastric cancer mortality (RR=1.48, 95%CI=1.06–2.02, P<0.05), and a 28% higher risk of all-cause malignancy mortality (RR=1.28, 95%CI=1.12–1.46, P<0.05) compared with the unscreened group. Cost-effectiveness analysis showed that the cost-effectiveness ratio of the project was 55,600 yuan, the average cost per early case detected was 87,000 yuan, and the early detection cost coefficient was 1.25.
[Conclusion]?The Yandu District Huai River Basin Upper Gastrointestinal Cancer Early Diagnosis and Treatment Project has good cost-effectiveness. The incidence density, mortality density, and relative risks of incidence and mortality for malignant tumors were higher in the screening group than in the unscreened group, suggesting that screening may help detect more patients and facilitate early detection of upper gastrointestinal cancer, thereby reducing the population-based incidence and mortality. |